Related Experiment Videos

Platelet aggregability to platelet activating factor at rest and after exercise in patients with coronary artery

J Goudevenos1, A D Tselepis, D Tsoukatos

  • 1Department of Cardiology, Medical School, University of Ioannina, Greece.

European Heart Journal
|August 1, 1995
PubMed

Insights

Platelet-activating factor (PAF) causes increased platelet aggregation in coronary artery disease patients with positive exercise tests. This heightened response, linked to altered PAF-acetylhydrolase (PAF-AH) activity and lipid profiles, suggests a role in cardiovascular disease progression.

Area of Science:

  • Cardiovascular Research
  • Platelet Physiology
  • Lipid Metabolism

Background:

  • Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation and thrombosis.
  • Elevated PAF levels and altered PAF-acetylhydrolase (PAF-AH) activity are implicated in cardiovascular diseases.
  • The relationship between PAF response, PAF-AH activity, and lipid profiles in coronary artery disease (CAD) patients during exercise stress warrants further investigation.

Purpose of the Study:

  • To investigate the platelet response to PAF in CAD patients undergoing exercise tests.
  • To correlate platelet aggregation with blood PAF levels, serum PAF-AH activity, and lipidaemic profiles.
  • To differentiate these responses between CAD patients with positive and negative exercise test results.

Main Methods:

  • Studied 44 CAD patients and 21 normal subjects, assessing platelet-activating factor (PAF) EC50 and maximal aggregation.
  • Measured whole-blood PAF levels and serum PAF-acetylhydrolase (PAF-AH) activity at rest and post-exercise.
  • Analyzed correlations between PAF response, PAF-AH activity, and serum lipid profiles (total and LDL cholesterol).

Main Results:

  • CAD patients with positive exercise tests showed significantly decreased PAF EC50 and increased maximal platelet aggregation at rest compared to controls.
  • No significant differences in PAF response were observed in patients with negative exercise tests.
  • Elevated resting PAF-AH activity was found in positive exercise test patients, correlating with lipids in controls and negative test groups, but not in positive test patients.

Conclusions:

  • CAD patients with positive exercise tests exhibit heightened platelet sensitivity to PAF, independent of exercise-induced changes.
  • Increased PAF-AH activity in these patients may be linked to their lipid profiles, but the correlation is lost in the positive exercise test group.
  • These findings suggest a potential role for PAF dysregulation and altered PAF-AH activity in the pathophysiology of coronary artery disease.

Related Concept Videos